After 3 great years with a fantastic consortium, the funded @paradise-project.bsky.social project ends with an excellent meeting in @scilifelab.se. Thanks to hosts Peter Nilsson, Elisa Pin and Lotta Prager. The concept of relapse prediction in AAV and the PARADISE consortium live on! #vasculitis
The Queen of IDIBELL trio!
Our last Paradise meeting! 3 years of thinking, learning and try to improve relapse prediction in AAV! Thanks all the consortium and Mark for the opportunity! @paradise-project.bsky.social @thkc.bsky.social
2025 Year in Review: Top 10 viewed articles in ACR Open Rheumatology banner
✨ Top 10 most-viewed articles published in ACR Open Rheumatology in 2025 ✨
3️⃣ Safety of Avacopan for the Treatment of ANCA-Associated Vasculitis: Combined Data From Three Clinical Trials
https://doi.org/10.1002/acr2.70001
#KPMP is ending 2025 on a high note with our Q4 2025 Kidney Tissue Atlas Release dropping today 🥳🎉 What are you waiting for? Go check out the explorer, repository AND spatial viewer release highlights!
atlas.kpmp.org
#Kidney #Atlas #Nephrology #PrecisionMedicine #OpenAccess #Data #PublicData
📣 I am hiring a postdoc! aial.ie/hiring/postd...
applications from suitable candidates that are passionate about investigating the use of genAI in public service operations with the aim of keeping governments transparent and accountable are welcome
pls share with your networks
A stunning new RPGN #spatiotranscriptomic kidney atlas, including n=32 #ANCA #vasculitis. Bravo to all in the Hamburg team! 🙌
www.nature.com/articles/s41...
Int Society of Nephrology Glomerular Disease fellowships! Our program is not on the small ISN list but can host ISN fellows. We offer glomerular disease clinics, vasculitis clinics, genetics clinics, onconeph clinics and research opportunities. DM if interested!
www.theisn.org/in-action/gr...
Our letter to Minister O'Brien — calling for urgent climate, health and biodiversity action.
We’ve set out the key priorities we must deliver for a healthier, greener and more resilient future for all.
#ClimateAction = #HealthAction
This May, we dedicated our time to raising awareness about vasculitis – and what better way to wrap it up than with a video featuring our incredible patient and public representatives 🎥✨
They’re not just part of the project – they’re the heart of PARADISE.
youtube.com/shorts/d4fo8...
A true pleasure to contribute to the 6th #euvas25 course in beautiful Trieste. Great to be back among #vasculitis friends, even if the weather was more like Dublin. @paradise-project.bsky.social
Always an emotional and important day for our students: commencements as trained doctors in the beautiful @tcddublin.bsky.social exam hall.
🎨Beautiful visual abstract by Divya Bajpai
#NephJC
http://www.nephjc.co
Next week starts the 6th EUVAS Vasculitis Course in Trieste !
#VAM2025
euvas.it
Registration link: attendee.gotowebinar.com/register/317...
#VAM2025
#VAM2025
attendee.gotowebinar.com/register/240...
Happening more and more with other respected journals also.
Only a small group of people genuinely NEED to drive a SUV.
For everyone else, it’s time to ban them!
May is almost here !! PARADISE Project is happy to introduce you in the month of Vasculitis Awareness #VAM2025
A true pleasure to host Silvia Vega in TTMI @tcddublin.bsky.social for the last few months. Come back soon! @julianadraibe.bsky.social
TTMI looking gorgeous 🙂
@tcddublin.bsky.social
I wonder are established journals starting to file law suits against predatory journals that use almost exactly the same journal title?
We had a wonderful time of exchange during these 2 days of our Plenary meeting. Many thanks to @uni-freiburg.de and Moritz team for hosting and #EPPerMed to finance #PARADISEProject.
@thkc.bsky.social @adaptcentre.bsky.social @julianadraibe.bsky.social
@davidselby.bsky.social
A highly appropriate restaurant in #freiburg for the @paradise-project.bsky.social consortium dinner.
Who knew that #frankfurt was so chilled out and beautiful? Looking forward to the annual @paradise-project.bsky.social meeting in Freiburg tomorrow. Lots of #AI in #autoimmune disease 🙂
Visual abstract
More (retrospective) data on the use of cyclophosphamide + rituximab in ANCA vasculitis in @kireports.bsky.social
VA from @kajareeg.bsky.social
www.kireports.org/article/S246...
#NephSky
CKD-MBD still undefeated in its ability to generate negative trials!
This study sounds like a three-foot putt. How can sevelamer not be better at reducing propensity toward calcification? I don't know but P=0.8.
Unmissable pragmatic clinical approach to #dementia podcasts.apple.com/ie/podcast/t...
We greatly enjoyed hosting Charlotte Velde-Keyzer for the last week, funded by an ERN-RITA mobility award. Hoping to use this as a springboard for an exciting collaboration between @paradise-project.bsky.social and @umcgroningen.bsky.social